FDA approves drug application for Lupin’s heart failure therapy
Sacubitril and Valsartan tablets are the generic equivalent of Novartis' Entresto.
Therapy Area
Biogen’s higher dose Spinraza under review by US and EU regulators
FDA grants ODD status to Zai Lab’s lung cancer treatment
FDA adds boxed warning to multiple sclerosis drugs after anaphylaxis cases
FDA breakthrough status for Bluejay’s CHD therapy brelovitug
CEPI provides $6.2m to push first mRNA-based Rift Valley fever vaccine into trial
Health Canada gives Takeda’s mCRC capsules market authorisation
EC approves GSK’s Jemperli-chemo combo for endometrial cancer
